This activity is hosted on the site of our educational partner

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

  • Overview
  • Pre-Assessment
  • Activity
  • Post-Test
  • Claim Credit
Antiretroviral Therapy Progress

Antiretroviral Therapy Progress

Format

Webcast

Time to Complete

45 minutes

Released

June 30, 2017

Expires

June 30, 2018
Add to Queue


Maximum Credits

0.75 / AMA PRA Category 1 CreditTM

Dowloadable PDF of content slides

Click here to download a copy of the slide deck.

Accredited Provider



Provided by Albert Einstein College of Medicine

Commercial Supporter

This activity is supported by educational grants from Gilead Sciences, AbbVie, Bristol-Myers Squibb, Merck, and Janssen Therapeutics.

Program Description


HIV and Hepatitis Management 2017: THE NEW YORK COURSE - Antiretroviral Therapy Progress
This advanced continuing medical education activity will provide participants with state-of-the-art education and practical guidance from nationally and internationally recognized experts on HIV infection and related comorbidities.

Intended Audience

This continuing education activity was planned to meet the needs of clinicians who treat patients with HIV.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Identify investigational HIV drugs in existing mechanistic drug classes
  • Identify investigational HIV drugs in novel mechanistic drug classes
  • Discuss potential uses of investigational HIV drugs for HIV treatment

Disclaimer

The material is prepared based on a review of multiple sources of information but is not exhaustive of the subject matter. Therefore, healthcare professionals and other individuals should review and consider other publications and materials about the subject matter rather than relying solely on the information contained in this material.

The information presented at this CME program represents the views and opinions of the individual presenters, and does not constitute the opinion or endorsement of or promotion by Albert Einstein College of Medicine, Montefiore Medical Center, Mentor Planning & Consulting, Inc., or the program grantors. Reasonable efforts have been made to present educational subject matter in a balanced, unbiased fashion and in compliance with regulatory requirements. Each participant must use his/her personal and professional judgment when considering further application of this information, particularly as it may relate to patient diagnostic or treatment decisions including, without limitation, FDA-approved uses and any off-label uses.

Faculty Disclosure Policy

The "Conflict of Interest Disclosure Policy" of Albert Einstein College of Medicine requires that faculty participating in any CME activity and anyone in a position to influence content disclose to the audience any relationship(s) with a pharmaceutical or equipment company. Any presenter whose disclosed relationships prove to create a conflict of interest with regard to their contribution to the activity will not be permitted to present.

The Albert Einstein College of Medicine also requires that faculty participating in any CME activity and anyone in a position to influence content disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.

Faculty

Roy M. Gulick, MD, MPH
Rochelle Belfer Professor in Medicine
Chief, Division of Infectious Diseases
Weill Cornell Medical College
New York, NY

Dr. Gulick has not had financial arrangements or affiliations with commercial or equipment companies during the last twelve months.

Credit

0.75

Type

AMA PRA Category 1 Credit(s)TM

Accreditation Statement

The activity has been planned and implemented in accordance with requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Albert Einstein College of Medicine and Mentor Planning & Consulting, Inc. Albert Einstein College of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Designation Statement

The Albert Einstein College of Medicine designates this Internet Enduring Material for a maximum of 0.75 AMA PRA Category 1 creditsTM . Physicians should claim only credit commensurate with the extent of their participation in the activity.

Planners' and Managers' Disclosures

The staff of Mentor Planning & Consulting, Inc. and Hospital Learning Centers, Inc. have nothing to disclose relative to this educational activity. The Center for Continuing Medical Education staff at Albert Einstein College of Medicine has no disclosures to report relevant to this activity.

Method of Participation

There are no fees to participate in this activity. To receive credit, participants must (1) read the intended audience, learning objectives, and disclosure statements, (2) complete the educational activity online, and (3) complete the post-test. It is estimated that this activity will take approximately 45 minutes. To receive AMA PRA Category 1 CreditTM  participants must receive a minimum score of 70% on the post-test. Your online certificate will be saved on myCME within your CME History, which you can access at any time.

Privacy Policy

SYSTEM REQUIREMENTS

Hardware and Software Requirements
  • A computer with an internet connection
  • Internet Browser: Internet Explorer 7.x or higher, Firefox 4.x or higher, Safari 2.x or higher, or any other W3C standards compliant browser
  • Additional Software: Adobe Flash Player and/or an HTML 5 capable browser maybe required for video or audio playback. PowerPoint or Adobe Acrobat Reader may occasionally be required
Add to Queue